Kim Byung Sun, Hwang Hye Seong, Park Heajin, Kim Ha Hyung
Biotherapeutics and Glycomics Laboratory, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 156-756, Republic of Korea.
Biotherapeutics and Glycomics Laboratory, College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul 156-756, Republic of Korea.
Biochim Biophys Acta. 2015 Sep;1850(9):1815-21. doi: 10.1016/j.bbagen.2015.05.011. Epub 2015 May 21.
Maackia amurensis leukoagglutinin (MAL) is a glycoprotein and sialic acid-binding lectin that is used widely in the detection and characterization of sialoglycoconjugates and human cancer cells. However, its N-linked glycan structure and role have yet to be determined.
The N-linked glycans were analyzed using high-performance liquid chromatography with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and the secondary structure was investigated using circular dichroism analysis. A hemagglutination assay was performed. Furthermore, surface plasmon resonance analysis, and fluorescence microscopy and fluorescence-activated cell-sorting analysis were conducted to assess the sialoglycoprotein-binding ability and its usefulness in the detection of human breast cancer MCF-7 cells, respectively.
Analysis of the N-linked glycan structure of MAL confirmed the presence of eight glycans, comprising two α1,3-fucosylated paucimannosidic-type and six high-mannose-type glycans. Glycan analysis of MAL that had been treated with peptide N-glycosidase F (de-M-MAL) revealed that while the two α1,3-fucosylated paucimannosidic glycans remained attached following the treatment, the six high-mannose-type glycans had been completely cleaved from the original MAL. There were almost no secondary structural changes between MAL and de-M-MAL; however, the lectin activities exhibited by MAL, such as hemagglutination and binding to a sialoglycoprotein, were completely absent in de-M-MAL, and the ability to detect human breast cancer MCF-7 cells was 77% lower in de-M-MAL than in MAL.
The high-mannose-type glycans in intact MAL are closely associated with its lectin activities.
This is the first report of the N-linked glycan structure of MAL and the effect of high-mannose-type glycans on lectin activities.
山槐凝集素(MAL)是一种糖蛋白和唾液酸结合凝集素,广泛用于唾液酸糖缀合物和人类癌细胞的检测与表征。然而,其N-连接聚糖结构和作用尚未确定。
使用高效液相色谱结合基质辅助激光解吸/电离飞行时间质谱分析N-连接聚糖,并使用圆二色性分析研究二级结构。进行血凝试验。此外,分别进行表面等离子体共振分析、荧光显微镜和荧光激活细胞分选分析,以评估其唾液酸糖蛋白结合能力及其在检测人乳腺癌MCF-7细胞中的效用。
对MAL的N-连接聚糖结构分析证实存在8种聚糖,包括两种α1,3-岩藻糖基化的寡甘露糖型聚糖和6种高甘露糖型聚糖。对用肽N-糖苷酶F处理的MAL(去糖基化MAL)进行聚糖分析表明,处理后两种α1,3-岩藻糖基化的寡甘露糖聚糖仍附着,但6种高甘露糖型聚糖已从原始MAL中完全切割。MAL和去糖基化MAL之间几乎没有二级结构变化;然而,去糖基化MAL中完全没有MAL表现出的凝集素活性,如血凝和与唾液酸糖蛋白的结合,并且去糖基化MAL检测人乳腺癌MCF-7细胞的能力比MAL低77%。
完整MAL中的高甘露糖型聚糖与其凝集素活性密切相关。
这是关于MAL的N-连接聚糖结构以及高甘露糖型聚糖对凝集素活性影响的首次报道。